Abbott highlights 95% Cologuard detection: stock after-hours at EUR 91.60
Published on 10/13/2026 at 23:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCampaign details and daily balance
- Abbott's October 13, 2026 campaign promotes Cologuard Plus, which the release says detects 95 percent of colorectal cancers.
- Abbott Laboratories stock trades after-hours at EUR 91.60 at 10:58 p.m. CEST at Lang & Schwarz on October 13, 2026.
- The Lang & Schwarz bid was EUR 90.90 and the ask was EUR 92.30.
- The next Xetra session is scheduled for October 14, 2026.
Abbott Laboratories launched its Mind Your Behind campaign on October 13, 2026, according to an Abbott MediaRoom release. The campaign promotes colorectal cancer screening with Cologuard Plus and features baseball players Albert Pujols and Cal Raleigh. Abbott said the test is a noninvasive, at-home option for adults 45 and older at average risk and detects 95 percent of colorectal cancers.
Today's trading day
Abbott Laboratories stock trades after-hours at EUR 91.60 at 10:58 p.m. CEST at Lang & Schwarz on October 13, 2026.
The bid was EUR 90.90 and the ask was EUR 92.30. The S&P 500 fell 1.79 points, or less than 0.1 percent, to 7,805.45 on October 13, 2026, according to WTOP News. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott campaign targets screening
The Abbott release said the campaign uses humorous videos in English and Spanish to encourage screening. It also said the Cologuard Plus test can be used at home in about 15 minutes without special preparation, and that colorectal cancer screening should begin at age 45 for average-risk adults.
Tomorrow
The next Xetra session is scheduled for October 14, 2026.
Market context: Market report S&P 500.
